TITLE

Laminin γ2 fragments are increased in the circulation of patients with early phase acute lung injury

AUTHOR(S)
Katayama, Masahiko; Ishizaka, Akitoshi; Sakamoto, Michiie; Fujishima, Seitaro; Sekiguchi, Kiyotoshi; Asano, Koichiro; Betsuyaku, Tomoko; Kotani, Toru; Ware, Lorraine B.; Matthay, Michael A.; Hashimoto, Satoru
PUB. DATE
March 2010
SOURCE
Intensive Care Medicine;Mar2010, Vol. 36 Issue 3, p479
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Laminin-5, a cell adhesive molecule expressed solely by epithelium, is known to enhance epithelial cell migration and repair of injured epithelium, after its essential component γ2-chain is processed proteolytically. Our previous study revealed circulating levels of amino-terminal fragment of laminin γ2-chain (G2F) reflect epithelial tumor invasiveness in carcinoma patients, but its physiological role in alveolar epithelial injury remains unknown. Sampling of epithelial lining fluids or pulmonary edema fluids from patients with acute lung injury (ALI) or related diseases was performed. Plasma samples were obtained from them at the time of disease onset or later. G2F concentrations were determined by immunoassay constructed by ourselves. We found a significantly higher amount of G2F in pulmonary edema and epithelial lining fluids of patients with ALI, as compared with those with the other respiratory diseases. Their plasma levels were also elevated significantly early at the onset of ALI (mean ± SD; 147 ± 82 ng/ml in non-surviving and 90 ± 56 in surviving patients) as compared with those in the patients with cardiogenic pulmonary edema (59 ± 36) or idiopathic pulmonary fibrosis (37 ± 17), indicating alveolar epithelium rapidly secrete laminin-5 in ALI. At 5 days after onset, non-surviving patients maintained higher plasma concentrations (152 ± 84), but in contrast, the levels in surviving patients declined (71 ± 35), suggesting secretion of laminin-5 was suppressed, associated with recovery from ALI. Circulating G2F may be a biomarker for alveolar laminin-5 secreted early at disease onset in ALI, potentially regulating alveolar re-epithelialization.
ACCESSION #
48004585

 

Related Articles

  • Surfactant Protein A (SP-A) and Angiotensin Converting Enzyme (ACE) as Early Biomarkers for Pulmonary Edema Formation in Ventilated Human Lung Lobes. Gnadt, Mirjam; Kardziev, Boris; Schmidt, Michael; Högger, Petra // Lung;Aug2012, Vol. 190 Issue 4, p431 

    Objective: Ex vivo perfused and ventilated lung lobes frequently develop pulmonary edema. We were looking for a suitable and early detectable biomarker in the perfusion fluid indicating lung cell damage and loss of tissue integrity in ventilated human lung lobes. Therefore, we elucidated whether...

  • Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing. Silvestri, Alessandra; Colombatti, Alfonso; Calvert, Valerie S.; Jianghong Deng; Mammano, Enzo; Belluco, Claudio; de Marchi, Francesco; Nitti, Donato; Liotta, Lance A.; Petricoin, Emanuel F.; Pierobon, Mariaelena // Laboratory Investigation (00236837);May2010, Vol. 90 Issue 5, p787 

    Tissues are complex structures composed of different cell types, each of which present specific functions and characteristics. To better understand and measure the effect of tumor cell enrichment on protein pathway profiling and drug target activation measurements, the signaling activation...

  • Biomarkers.  // Annals of Oncology;May2012 Supplement 2, Vol. 23 Issue suppl_2, pii17 

    No abstract available.

  • Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate. Mounier, C. M.; Wendum, D.; Greenspan, E.; Fléjou, J.-F.; Rosenberg, D. W.; Lambeau, G.; Fléjou, J-F // British Journal of Cancer;2/5/2008, Vol. 98 Issue 3, p587 

    Recent studies suggest that secreted phospholipases A2 (sPLA2s) represent attractive potential tumour biomarkers and therapeutic targets for various cancers. As a first step to address this issue in human colorectal cancer, we examined the expression of the full set of sPLA2s in sporadic...

  • The proteome of Hypobaric Induced Hypoxic Lung: Insights from Temporal Proteomic Profiling for Biomarker Discovery. Ahmad, Yasmin; Sharma, Narendra K.; Sharma, Manish; Garg, Iti; Srivastava, Mousami; Bhargava, Kalpana; Ahmad, Mohammad Faiz // Scientific Reports;5/29/2015, p10681 

    Exposure to high altitude induces physiological responses due to hypoxia. Lungs being at the first level to face the alterations in oxygen levels are critical to counter and balance these changes. Studies have been done analysing pulmonary proteome alterations in response to exposure to...

  • Thymus by numbers. Petrie, Howard T.; van Ewijk, Willem // Nature Immunology;Jul2002, Vol. 3 Issue 7, p604 

    The identity of the thymic epithelium precursor has been elusive. A marker is now shown to identify a population of cells that can give rise to a functional thymus.

  • Metronomics in low and middle income countries: India showing the way! André, N.; Pasquier, E. // Indian Journal of Cancer;Apr-Jun2013, Vol. 50 Issue 2, p112 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the need for biomarkers to patients monitoring, the esophageal cancer treatments and the use of metronomic weekly paclitaxel on non-small-cell lung cancer.

  • Adiponectin as a Potential Marker of Prostate Cancer Progression: Studies in Organ-Confined and Locally Advanced Prostate Cancer. Housa, D.; Vernerová, Z.; Heráček, J.; Procházka, B.; Čechák, P.; Kuncová, J.; Haluzík, M. // Physiological Research;2008, Vol. 57 Issue 3, p451 

    Serum levels of adiponectin were measured in patients with benign prostatic hyperplasia and prostate cancer of pT2 and pT3 stage. Adiponectin ELISA assay, immunohistochemistry, and selected metabolic and biochemical parameters measurement was performed in 25 patients with benign prostatic...

  • Tumour markers: their use and misuse by clinicians. McGinley, Peter J; Kilpatrick, Eric S // Annals of Clinical Biochemistry;Nov2003, Vol. 40 Issue 6, p643 

    Background: Several guidelines exist on the appropriate use of serum tumour markers in the management of patients with cancer. This study audited tumour marker requesting against these guidelines in a busy teaching hospital over a 12-month period. Methods: All marker requests from 1 April 2001...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics